eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2023
vol. 48
 
Share:
Share:
abstract:
Clinical immunology

Prognostic value and immunological role of PTPN21 in pan-cancer analysis

Yane Yang
1
,
WenChao Yang
1
,
Xingxing Su
2
,
CaiXia Cheng
2, 3

  1. School of Public Health, Shanxi Medical University, China
  2. The First Clinical Medical College, Shanxi Medical University, China
  3. Department of Pathology, The First Hospital, Shanxi Medical University, China
Cent Eur J Immunol 2023; 48 (2): 111-125
Online publish date: 2023/07/20
View full text Get citation
 
PlumX metrics:
Introduction:
At present, cancer remains a persistent public health challenge facing the whole world. Studies have found that PTPN21 is associated with the development of cancer. However, the prognostic potential of PTPN21 in pan-cancer remains unclear. In this work, we aimed to analyze the expression and prognostic value of PTPN21 in pan-cancer and to further study the relationship between PTPN21 and immune infiltration.

Material and methods:
TCGA and GEO data were used for expression and survival analysis. Genetic alterations in PTPN21 from TCGA cancer were studied in cBioPortal. TIMER2 was used to evaluate the correlation between PTPN21 expression and immune infiltration. The R packages “ggplot2” and “clusterProfiler” were used for GO and KEGG analysis.

Results:
PTPN21 was found to be a valuable diagnostic biomarker in multiple cancers, including bladder urothelial carcinoma (BLCA), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), and lung squamous cell carcinoma (LUSC). In addition, we observed that PTPN21 expression was associated with a variety of tumor mutations. Our results indicated a correlation between PTPN21 expression and immune infiltration. Enrichment analysis showed that PTPN21 was mainly involved in the regulation of neuroactive ligand-receptor interaction.

Conclusions:
Our study showed that PTPN21 expression is associated with clinical prognosis, mutation, and immune infiltration of tumors. PTPN21 may be a potential biomarker for many cancers, especially in KIRC.

keywords:

PTPN21, prognosis, immune infiltration, mutation, pan-cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.